Organism: Homo sapiens
Gene: 40556_at
Selected probe(set): 201063_at
Platform: Affymetrix Human Genome U133 Plus 2.0 Array

Expression of 40556_at (201063_at) across 6672 perturbations tested by GENEVESTIGATOR:

Relative Expression (log2-ratio):-4.9498386
Number of Samples:4 / 4

Experimental	OPM-1
	Human primary cancer cell line derived from the peripheral blood of a patient with multiple myeloma. Dexamethasone-resistant. Synonyms:OPM1 Cellosaurus code:
Control	MM1.S
	Human primary cancer cell line derived from the peripheral blood of a patient with multiple myeloma. Dexamethasone-sensitive. Parental cell line:: MM.1 Synonyms:MM.1S; MM1-S; MM-1S; MM1S Cellosaurus code:

Relative Expression (log2-ratio):3.7455282
Number of Samples:3 / 4

Experimental	expO kidney cancer study 1 (renal cell carcinoma, sarcomatoid; primary)
	Primary tumor tissue samples obtained from the kidney of patients with renal cell carcinoma, sarcomatoid.
Control	expO kidney cancer study 1 (granular cell carcinoma; primary)
	Primary tumor tissue samples obtained from the kidney of patients with granular cell carcinoma.

Relative Expression (log2-ratio):-3.2129345
Number of Samples:2 / 2

Experimental	LPS study 4 (shRNA contr.)
	MONO-MAC-6 (MM6) cells were transduced with a control shRNA and then treated with 10 ng/ml lipopolysaccharide (LPS). ATC code:---
Control	mock treated / transduced MONO-MAC-6 cell sample
	MONO-MAC-6 (MM6) cells were transduced with a control shRNA and then mock treated.

Relative Expression (log2-ratio):-2.864832
Number of Samples:2 / 3

Experimental	CNS cancer study 1 (PDX; glioma, malignant, NOS; primary)
	Patient-derived xenograft (PDX) samples generated in female athymic nude mice from patients with primary glioma, malignant, NOS of the central nervous system (subcutaneously implanted).
Control	CNS cancer study 1 (PDX; glioblastoma, NOS; primary)
	Patient-derived xenograft (PDX) samples generated in female athymic nude mice from patients with primary glioblastoma, NOS of the central nervous system (subcutaneously implanted).

Relative Expression (log2-ratio):-2.793562
Number of Samples:2 / 2

Experimental	CNS cancer study 1 (PDX; glioma, malignant, NOS; primary)
	Patient-derived xenograft (PDX) samples generated in female athymic nude mice from patients with primary glioma, malignant, NOS of the central nervous system (subcutaneously implanted).
Control	CNS cancer study 1 (PDX; ependymoma, NOS; primary)
	Patient-derived xenograft (PDX) samples generated in female athymic nude mice from patients with primary ependymoma, NOS of the central nervous system (subcutaneously implanted).

Relative Expression (log2-ratio):2.7233496
Number of Samples:5 / 4

Experimental	expO kidney cancer study 1 (renal cell carcinoma, NOS; primary)
	Primary tumor tissue samples obtained from the kidney of patients with renal cell carcinoma (NOS).
Control	expO kidney cancer study 1 (granular cell carcinoma; primary)
	Primary tumor tissue samples obtained from the kidney of patients with granular cell carcinoma.

Relative Expression (log2-ratio):2.6784248
Number of Samples:3 / 3

Experimental	VTX-2337 study 1
	Peripheral blood monocytes isolated from healthy donors. Cells were treated overnight with 1uM VTX-2337 drug, which represents a TLR8 (Toll-like receptor 8) agonist with potential immunostimulating and antineoplastic activities.
Control	3M-055 study 1
	Peripheral blood monocytes isolated from healthy donors. Cells were treated overnight with 1uM 3M-055 drug, which represents a TLR7 (Toll-like receptor 7) agonist.

Relative Expression (log2-ratio):2.6125107
Number of Samples:2 / 2

Experimental	T-cell activation study 3
	CD4+ T-cell samples prepared from crude lymphocyte fraction. Cells were activated with anti-CD3/28 beads for 18hrs.
Control	resting CD4 T-lymphocyte (crude fraction) sample
	Resting CD4 T-lymphocytes prepared from crude lymphocyte fraction.

Relative Expression (log2-ratio):2.5955925
Number of Samples:2 / 2

Experimental	T-cell activation study 1
	CD4+ T-cell samples derived from PBMC´s of HIV-seronegative donors were activated with plate bound CD3 (1ug/ml) and soluble CD28 (50ng/ml) for 1 day.
Control	quiescent CD4+ T-cell sample
	Quiescent CD4+ T-cell samples derived from PBMC´s of HIV-seronegative donors.

Relative Expression (log2-ratio):2.5949688
Number of Samples:36 / 74

Experimental	AML study 1 (t(15;17)(q22;q11-12))
	Bone marrow samples of patients with acute promyelocytic leukemia [subtype of acute myeloid leukemia (AML)] with genetic aberration (t(15;17)(q22;q11-12)/PML-RARα and variations).
Control	normal bone marrow sample
	Non-leukemic and healthy bone marrow sample.